CIK 0001802665
- Large accelerated filer
Harmony Biosciences Holdings, Inc.
Sign in to watch- Ticker
- HRMY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822279923
- Phone
- +1 484-539-9800
- Business address
- 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, 19462
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,987 shares at an average $32.54 ($227,386)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 8,014 shares (to pay taxes)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 4,869 shares at an average $32.67 ($159,090)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,151 shares (to pay taxes)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 14,754 shares at an average $37.38 ($551,575)
- 4 Shares withheld for taxes PRESIDENT, CEO gave up 4,567 shares (to pay taxes)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,775 shares at $38.05 ($67,547)
- 4 Shares withheld for taxes CHIEF STRATEGY OFFICER gave up 865 shares (to pay taxes)
- 4 Planned sale PRESIDENT, CEO sold 19,293 shares at $40.13 ($774,245)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 25,000 shares at $40.18 ($1,004,598)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 30,598 shares at an average $37.51 ($1,147,715)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 10,507 shares at $37.01 ($388,841)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 7,180 shares at $37.04 ($265,946)
- 4 Open-market sale 10% owner sold 4,600,000 shares at $30.30 ($139,391,500)
- 4 Open-market sale 10% owner sold 4,600,000 shares at $30.30 ($139,391,500)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 21,496 shares at $40.47 ($870,018)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 36,357 shares at an average $35.06 ($1,274,547)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 400 shares at $40.19 ($16,077)
Page 3 of 11 · 213 filings